Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Receptor imaging in the diagnosis and treatment of pituitary tumors.

× No keyword cloud information.

12 in total

Review 1. Receptor imaging in the diagnosis and treatment of pituitary tumors.

Authors: D J Kwekkeboom; W W de Herder; E P Krenning
Journal: J Endocrinol Invest Date: 1999-01 Impact factor: 4.256

Review 2. The role of somatostatin and its analogs in the diagnosis and treatment of tumors.

Authors: S W Lamberts; E P Krenning; J C Reubi
Journal: Endocr Rev Date: 1991-11 Impact factor: 19.871

3. In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand.

Authors: W W de Herder; A E Reijs; D J Kwekkeboom; L J Hofland; F R Nobels; H Y Oei; E P Krenning; S W Lamberts
Journal: Clin Endocrinol (Oxf) Date: 1996-12 Impact factor: 3.478

4. The pituitary uptake of (111)In-DTPA-D-Phe1-octreotide in the normal pituitary and in pituitary adenomas.

Authors: A Colao; S Lastoria; D Ferone; P Varrella; P Marzullo; R Pivonello; G Cerbone; W Acampa; M Salvatore; G Lombardi
Journal: J Endocrinol Invest Date: 1999-03 Impact factor: 4.256

5. Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas.

Authors: D Ferone; S Lastoria; A Colao; P Varrella; G Cerbone; W Acampa; B Merola; M Salvatore; G Lombardi
Journal: J Clin Endocrinol Metab Date: 1998-01 Impact factor: 5.958

6. Dopamine agonists and pituitary tumor shrinkage.

Authors: J S Bevan; J Webster; C W Burke; M F Scanlon
Journal: Endocr Rev Date: 1992-05 Impact factor: 19.871

7. Imaging of dopamine D2 and somatostatin receptors in vivo using single-photon emission tomography in a patient with a TSH/PRL-producing pituitary macroadenoma.

Authors: N P Verhoeff; F J Bemelman; W M Wiersinga; E A van Royen
Journal: Eur J Nucl Med Date: 1993-06

8. Therapy of acromegaly with sandostatin: the predictive value of an acute test, the value of serum somatomedin-C measurements in dose adjustment and the definition of a biochemical 'cure'.

Authors: S W Lamberts; P Uitterlinden; P C Schuijff; J G Klijn
Journal: Clin Endocrinol (Oxf) Date: 1988-10 Impact factor: 3.478

9. Indium-111-DTPA-octreotide uptake measured in normal and abnormal pituitary glands.

Authors: E A van Royen; N P Verhoeff; S A Meylaerts; A R Miedema
Journal: J Nucl Med Date: 1996-09 Impact factor: 10.057

10. In vivo visualization of pituitary dopaminergic receptors by iodine-123 methoxybenzamide (IBZM) correlates with sensitivity to dopamine agonists in two patients with macroprolactinomas.

Authors: A Scillitani; F Dicembrino; P Di Fazio; P P Vettori; V D'Angelo; T Scarabino; A Liuzzi
Journal: J Clin Endocrinol Metab Date: 1995-08 Impact factor: 5.958

1 in total

1. 11C-methionine PET for the diagnosis and management of recurrent pituitary adenomas.

Authors: B N T Tang; M Levivier; M Heureux; D Wikler; N Massager; D Devriendt; P David; N Dumarey; B Corvilain; S Goldman
Journal: Eur J Nucl Med Mol Imaging Date: 2005-10-15 Impact factor: 9.236

1 in total